You are currently on the new version of our website. Access the old version .

60 Results Found

  • Review
  • Open Access
20 Citations
13,198 Views
24 Pages

The Molecular and Cellular Basis of Hutchinson–Gilford Progeria Syndrome and Potential Treatments

  • Noelle J. Batista,
  • Sanket G. Desai,
  • Alexis M. Perez,
  • Alexa Finkelstein,
  • Rachel Radigan,
  • Manrose Singh,
  • Aaron Landman,
  • Brian Drittel,
  • Daniella Abramov and
  • Dong Zhang
  • + 2 authors

27 February 2023

Hutchinson–Gilford progeria syndrome (HGPS) is a rare, autosomal-dominant, and fatal premature aging syndrome. HGPS is most often derived from a de novo point mutation in the LMNA gene, which results in an alternative splicing defect and the ge...

  • Case Report
  • Open Access
1 Citations
1,437 Views
2 Pages

Ranolazine Treatment for Refractory Angina in a Patient with Hutchinson-Gilford Progeria Syndrome and End Stage Aortic Stenosis

  • Giuseppe Limongelli,
  • Emanuele Monda,
  • Giovanbattista Capozzi,
  • Martina Caiazza and
  • Maria Giovanna Russo

Management of symptoms in patients with inoperable aortic stenosis is often hard in clinical practice. We report a case of a patient with Hutchinson-Gilford progeria syndrome and end-stage aortic stenosis, considered not suitable for surgical or perc...

  • Case Report
  • Open Access
1 Citations
2,728 Views
9 Pages

Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention in Hutchinson–Gilford Progeria

  • Luciano De Simone,
  • Serena Chiellino,
  • Gaia Spaziani,
  • Giulio Porcedda,
  • Giovan Battista Calabri,
  • Sergio Berti,
  • Silvia Favilli,
  • Laura Stefani and
  • Giuseppe Santoro

8 March 2023

Hutchinson–Gilford progeria syndrome is an extremely rare genetic disease caused by a de novo mutation in the LMNA gene, leading to an accumulation of a form of Lamin A, called Progerin, which results in a typical phenotype and a marked decreas...

  • Review
  • Open Access
452 Views
18 Pages

Why and How Are Infants with Hutchinson–Gilford Progeria Syndrome Born Without Severe Manifestations?

  • Mariia A. Erokhina,
  • Ekaterina A. Vorotelyak,
  • Andrey V. Vasiliev and
  • Vepa K. Abdyev

15 December 2025

Children with Hutchinson–Gilford progeria syndrome (HGPS) are born without height and weight abnormalities, and postnatal development is delayed from two months of age. The pathophysiological manifestations of HGPS can be categorized into the t...

  • Article
  • Open Access
13 Citations
5,385 Views
20 Pages

Rescue of Mitochondrial Function in Hutchinson-Gilford Progeria Syndrome by the Pharmacological Modulation of Exportin CRM1

  • Feliciano Monterrubio-Ledezma,
  • Fernando Navarro-García,
  • Lourdes Massieu,
  • Ricardo Mondragón-Flores,
  • Luz Adriana Soto-Ponce,
  • Jonathan J. Magaña and
  • Bulmaro Cisneros

10 January 2023

Hutchinson-Gilford progeria syndrome (HGPS) is a rare premature aging disorder caused by the expression of progerin, a mutant variant of Lamin A. Recently, HGPS studies have gained relevance because unraveling its underlying mechanism would help to u...

  • Case Report
  • Open Access
6 Citations
4,758 Views
11 Pages

Efficacy of Cord Blood Cell Therapy for Hutchinson–Gilford Progeria Syndrome—A Case Report

  • Mi Ri Suh,
  • Ikhyun Lim,
  • Jongwook Kim,
  • Pil-Sung Yang,
  • Jin Seung Choung,
  • Hye Ryeong Sim,
  • Sung Chan Ha and
  • MinYoung Kim

15 November 2021

Hutchinson–Gilford progeria syndrome (HGPS) is an extremely rare premature aging disorder characterized by short stature and atherosclerosis-induced death within teenage years. A 13-year-old male diagnosed with HGPS was administered three intravenous...

  • Communication
  • Open Access
9 Citations
4,078 Views
13 Pages

Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson–Gilford Progeria Syndrome

  • So-mi Kang,
  • Seungwoon Seo,
  • Eun Ju Song,
  • Okhee Kweon,
  • Ah-hyeon Jo,
  • Soyoung Park,
  • Tae-Gyun Woo,
  • Bae-Hoon Kim,
  • Goo Taeg Oh and
  • Bum-Joon Park

24 April 2023

Hutchinson–Gilford Progeria Syndrome (HGPS) is an ultra-rare human premature aging disorder that precipitates death because of cardiac disease. Almost all cases of HGPS are caused by aberrant splicing of the LMNA gene that results in the produc...

  • Review
  • Open Access
37 Citations
7,635 Views
20 Pages

11 May 2021

Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disease that recapitulates many symptoms of physiological aging and precipitates death. Patients develop severe vascular alterations, mainly massive vascular smooth muscle cell loss, vesse...

  • Review
  • Open Access
7 Citations
6,366 Views
11 Pages

18 January 2022

Alternative splicing (AS) is a biological operation that enables a messenger RNA to encode protein variants (isoforms) that give one gene several functions or properties. This process provides one of the major sources of use for understanding the pro...

  • Article
  • Open Access
12 Citations
3,684 Views
16 Pages

10 February 2022

Lysophosphatidic acid (LPA) is a growth factor-like lipid mediator that regulates various physiological functions via activation of multiple LPA G protein-coupled receptors. We previously reported that LPA suppresses oxidative stress in premature agi...

  • Feature Paper
  • Review
  • Open Access
31 Citations
15,781 Views
17 Pages

8 February 2020

Hutchinson–Gilford Progeria Syndrome (HGPS) is a segmental premature aging disease causing patient death by early teenage years from cardiovascular dysfunction. Although HGPS does not totally recapitulate normal aging, it does harbor many simil...

  • Review
  • Open Access
2 Citations
3,480 Views
19 Pages

18 December 2024

Hutchinson–Gilford progeria syndrome (HGPS) is a pediatric condition characterized by clinical features that resemble accelerated aging. The abnormal accumulation of a toxic form of the lamin A protein known as progerin disrupts cellular functi...

  • Review
  • Open Access
43 Citations
17,691 Views
22 Pages

Hutchinson-Gilford Progeria Syndrome—Current Status and Prospects for Gene Therapy Treatment

  • Katarzyna Piekarowicz,
  • Magdalena Machowska,
  • Volha Dzianisava and
  • Ryszard Rzepecki

25 January 2019

Hutchinson-Gilford progeria syndrome (HGPS) is one of the most severe disorders among laminopathies—a heterogeneous group of genetic diseases with a molecular background based on mutations in the LMNA gene and genes coding for interacting prote...

  • Review
  • Open Access
17 Citations
8,840 Views
16 Pages

Small-Molecule Therapeutic Perspectives for the Treatment of Progeria

  • Jon Macicior,
  • Beatriz Marcos-Ramiro and
  • Silvia Ortega-Gutiérrez

Hutchinson–Gilford progeria syndrome (HGPS), or progeria, is an extremely rare disorder that belongs to the class of laminopathies, diseases characterized by alterations in the genes that encode for the lamin proteins or for their associated interact...

  • Article
  • Open Access
1,089 Views
23 Pages

Impact of miR-181a on SIRT1 Expression and Senescence in Hutchinson–Gilford Progeria Syndrome

  • Eva-Maria Lederer,
  • Felix Quirin Fenzl,
  • Peter Krüger,
  • Moritz Schroll,
  • Ramona Hartinger and
  • Karima Djabali

4 August 2025

Background/Objectives: Hutchinson–Gilford progeria syndrome (HGPS) is a rare and fatal genetic disease caused by a silent mutation in the LMNA gene, leading to the production of progerin, a defective prelamin A variant. Progerin accumulation di...

  • Article
  • Open Access
8 Citations
3,885 Views
14 Pages

High-Throughput Screen Detects Calcium Signaling Dysfunction in Hutchinson-Gilford Progeria Syndrome

  • Juan A. Fafián-Labora,
  • Miriam Morente-López,
  • Fco. Javier de Toro and
  • María C. Arufe

Hutchinson–Gilford progeria syndrome (HGPS) is a deadly childhood disorder, which is considered a very rare disease. It is caused by an autosomal dominant mutation on the LMNA gene, and it is characterized by accelerated aging. Human cell lines from...

  • Review
  • Open Access
5 Citations
6,121 Views
17 Pages

Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS

  • Bae-Hoon Kim,
  • Yeon-Ho Chung,
  • Tae-Gyun Woo,
  • So-Mi Kang,
  • Soyoung Park and
  • Bum-Joon Park

18 September 2023

Hutchinson–Gilford progeria syndrome (HGPS) is an extremely rare genetic disorder caused by the mutant protein progerin, which is expressed by the abnormal splicing of the LMNA gene. HGPS affects systemic levels, with the exception of cognition...

  • Article
  • Open Access
14 Citations
3,608 Views
22 Pages

9 May 2023

Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic disease that causes premature aging symptoms, such as vascular diseases, lipodystrophy, loss of bone mineral density, and alopecia. HGPS is mostly linked to a heterozygous and de nov...

  • Review
  • Open Access
45 Citations
9,111 Views
18 Pages

5 September 2019

Ribosome biogenesis is one of the most energy demanding processes in the cell. In eukaryotes, the main steps of this process occur in the nucleolus and include pre-ribosomal RNA (pre-rRNA) processing, post-transcriptional modifications, and assembly...

  • Article
  • Open Access
10 Citations
4,403 Views
13 Pages

Establishment and Characterization of hTERT Immortalized Hutchinson–Gilford Progeria Fibroblast Cell Lines

  • Haihuan Lin,
  • Juliane Mensch,
  • Maria Haschke,
  • Kathrin Jäger,
  • Brigitte Köttgen,
  • Jens Dernedde,
  • Evelyn Orsó and
  • Michael Walter

6 September 2022

Hutchinson–Gilford progeria syndrome (HGPS) is a rare premature aging syndrome caused by a dominant mutation in the LMNA gene. Previous research has shown that the ectopic expression of the catalytic subunit of telomerase (hTERT) can elongate t...

  • Review
  • Open Access
1 Citations
4,545 Views
25 Pages

Lipodystrophic Laminopathies: From Dunnigan Disease to Progeroid Syndromes

  • Everardo Josué Díaz-López,
  • Sofía Sánchez-Iglesias,
  • Ana I. Castro,
  • Silvia Cobelo-Gómez,
  • Teresa Prado-Moraña,
  • David Araújo-Vilar and
  • Antia Fernandez-Pombo

28 August 2024

Lipodystrophic laminopathies are a group of ultra-rare disorders characterised by the presence of pathogenic variants in the same gene (LMNA) and other related genes, along with an impaired adipose tissue pattern and other features that are specific...

  • Review
  • Open Access
14 Citations
5,634 Views
13 Pages

4 June 2019

The nucleolus organizes around the sites of transcription by RNA polymerase I (RNA Pol I). rDNA transcription by this enzyme is the key step of ribosome biogenesis and most of the assembly and maturation processes of the ribosome occur co-transcripti...

  • Article
  • Open Access
5 Citations
4,142 Views
18 Pages

Impaired LEF1 Activation Accelerates iPSC-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome

  • Xiaojing Mao,
  • Zheng-Mei Xiong,
  • Huijing Xue,
  • Markus A. Brown,
  • Yantenew G. Gete,
  • Reynold Yu,
  • Linlin Sun and
  • Kan Cao

Hutchinson–Gilford progeria syndrome (HGPS) is a detrimental premature aging disease caused by a point mutation in the human LMNA gene. This mutation results in the abnormal accumulation of a truncated pre-lamin A protein called progerin. Among...

  • Review
  • Open Access
5 Citations
4,635 Views
37 Pages

Navigating Lipodystrophy: Insights from Laminopathies and Beyond

  • Peter Krüger,
  • Ramona Hartinger and
  • Karima Djabali

Recent research into laminopathic lipodystrophies—rare genetic disorders caused by mutations in the LMNA gene—has greatly expanded our knowledge of their complex pathology and metabolic implications. These disorders, including Hutchinson-...

  • Brief Report
  • Open Access
5 Citations
3,976 Views
11 Pages

Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry

  • Emilio Camafeita,
  • Inmaculada Jorge,
  • José Rivera-Torres,
  • Vicente Andrés and
  • Jesús Vázquez

3 October 2022

Hutchinson-Gilford progeria syndrome (HGPS) is a rare fatal disorder characterized by premature aging and death at a median age of 14.5 years. The most common cause of HGPS (affecting circa 90% of patients) is a de novo heterozygous synonymous single...

  • Review
  • Open Access
6 Citations
3,626 Views
16 Pages

4 December 2022

Ectopic calcification (EC) is characterized by an abnormal deposition of calcium phosphate crystals in soft tissues such as blood vessels, skin, and brain parenchyma. EC contributes to significant morbidity and mortality and is considered a major hea...

  • Article
  • Open Access
2 Citations
1,972 Views
12 Pages

Among various cardiac safety concerns, proarrhythmia risks, including QT prolongation leading to Torsade de Pointes, is one of major cause for drugs being withdrawn (~45% 1975–2007). Preclinical study requires the evaluation of proarrhythmia us...

  • Article
  • Open Access
11 Citations
4,244 Views
23 Pages

Inflammation and Fibrosis in Progeria: Organ-Specific Responses in an HGPS Mouse Model

  • Peter Krüger,
  • Moritz Schroll,
  • Felix Fenzl,
  • Eva-Maria Lederer,
  • Ramona Hartinger,
  • Rouven Arnold,
  • Deniz Cagla Togan,
  • Runjia Guo,
  • Shiyu Liu and
  • Karima Djabali
  • + 2 authors

28 August 2024

Hutchinson–Gilford Progeria Syndrome (HGPS) is an extremely rare genetic disorder that causes accelerated aging, due to a pathogenic variant in the LMNA gene. This pathogenic results in the production of progerin, a defective protein that disru...

  • Article
  • Open Access
20 Citations
4,322 Views
19 Pages

8 October 2020

Hutchinson–Gilford progeria syndrome (HGPS) is among the most devastating of the laminopathies, rare genetic diseases caused by mutations in genes encoding nuclear lamina proteins. HGPS patients age prematurely and die in adolescence, typically...

  • Article
  • Open Access
3 Citations
3,062 Views
23 Pages

Baricitinib and Lonafarnib Synergistically Target Progerin and Inflammation, Improving Lifespan and Health in Progeria Mice

  • Peter Krüger,
  • Moritz Schroll,
  • Felix Quirin Fenzl,
  • Ramona Hartinger,
  • Eva-Maria Lederer,
  • Agnes Görlach,
  • Leslie B. Gordon,
  • Paola Cavalcante,
  • Nicola Iacomino and
  • Karima Djabali
  • + 6 authors

Hutchinson–Gilford progeria syndrome (HGPS) is a rare, fatal, and premature aging disorder caused by progerin, a truncated form of lamin A that disrupts nuclear architecture, induces systemic inflammation, and accelerates senescence. While the...

  • Article
  • Open Access
60 Citations
7,125 Views
16 Pages

Progerin Expression Induces Inflammation, Oxidative Stress and Senescence in Human Coronary Endothelial Cells

  • Guillaume Bidault,
  • Marie Garcia,
  • Jacqueline Capeau,
  • Romain Morichon,
  • Corinne Vigouroux and
  • Véronique Béréziat

12 May 2020

Hutchinson–Gilford progeria syndrome (HGPS) is a rare premature aging disorder notably characterized by precocious and deadly atherosclerosis. Almost 90% of HGPS patients carry a LMNA p.G608G splice variant that leads to the expression of a per...

  • Article
  • Open Access
29 Citations
4,949 Views
11 Pages

Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment

  • Lara del Campo,
  • Amanda Sánchez-López,
  • Cristina González-Gómez,
  • María Jesús Andrés-Manzano,
  • Beatriz Dorado and
  • Vicente Andrés

8 March 2020

Cardiovascular disease (CVD) is the main cause of death worldwide, and aging is its leading risk factor. Aging is much accelerated in Hutchinson–Gilford progeria syndrome (HGPS), an ultra-rare genetic disorder provoked by the ubiquitous express...

  • Review
  • Open Access
29 Citations
7,714 Views
28 Pages

The Cutting Edge: The Role of mTOR Signaling in Laminopathies

  • Francesca Chiarini,
  • Camilla Evangelisti,
  • Vittoria Cenni,
  • Antonietta Fazio,
  • Francesca Paganelli,
  • Alberto M. Martelli and
  • Giovanna Lattanzi

15 February 2019

The mechanistic target of rapamycin (mTOR) is a ubiquitous serine/threonine kinase that regulates anabolic and catabolic processes, in response to environmental inputs. The existence of mTOR in numerous cell compartments explains its specific ability...

  • Review
  • Open Access
11 Citations
7,733 Views
46 Pages

A Link between Replicative Stress, Lamin Proteins, and Inflammation

  • Simon Willaume,
  • Emilie Rass,
  • Paula Fontanilla-Ramirez,
  • Angela Moussa,
  • Paul Wanschoor and
  • Pascale Bertrand

9 April 2021

Double-stranded breaks (DSB), the most toxic DNA lesions, are either a consequence of cellular metabolism, programmed as in during V(D)J recombination, or induced by anti-tumoral therapies or accidental genotoxic exposure. One origin of DSB sources i...

  • Review
  • Open Access
57 Citations
13,038 Views
33 Pages

Lamin A/C Mechanotransduction in Laminopathies

  • Francesca Donnaloja,
  • Federica Carnevali,
  • Emanuela Jacchetti and
  • Manuela Teresa Raimondi

24 May 2020

Mechanotransduction translates forces into biological responses and regulates cell functionalities. It is implicated in several diseases, including laminopathies which are pathologies associated with mutations in lamins and lamin-associated proteins....

  • Article
  • Open Access
7 Citations
2,925 Views
15 Pages

Statins as a Therapeutic Approach for the Treatment of Pseudoxanthoma Elasticum Patients: Evaluation of the Spectrum Efficacy of Atorvastatin In Vitro

  • Janina Tiemann,
  • Christopher Lindenkamp,
  • Ricarda Plümers,
  • Isabel Faust,
  • Cornelius Knabbe and
  • Doris Hendig

19 February 2021

Pseudoxanthoma elasticum (PXE) is an autosomal recessive disorder caused by mutations in the ATP-binding cassette sub-family C member 6 gene. Our previous studies revealed that PXE might be associated with premature aging. Treatment with statins show...

  • Review
  • Open Access
29 Citations
8,766 Views
21 Pages

Nuclear Organization in Stress and Aging

  • Raquel Romero-Bueno,
  • Patricia de la Cruz Ruiz,
  • Marta Artal-Sanz,
  • Peter Askjaer and
  • Agnieszka Dobrzynska

1 July 2019

The eukaryotic nucleus controls most cellular processes. It is isolated from the cytoplasm by the nuclear envelope, which plays a prominent role in the structural organization of the cell, including nucleocytoplasmic communication, chromatin position...

  • Review
  • Open Access
5,456 Views
16 Pages

Modelling Nuclear Morphology and Shape Transformation: A Review

  • Chao Fang,
  • Jiaxing Yao,
  • Xingyu Xia and
  • Yuan Lin

As one of the most important cellular compartments, the nucleus contains genetic materials and separates them from the cytoplasm with the nuclear envelope (NE), a thin membrane that is susceptible to deformations caused by intracellular forces. Inter...

  • Article
  • Open Access
16 Citations
7,597 Views
22 Pages

25 June 2021

Hutchinson–Gilford progeria syndrome (HGPS) is a segmental premature aging disease caused by a mutation in LMNA. The mutation generates a truncated and farnesylated form of prelamin A, called progerin. Affected individuals develop several features of...

  • Article
  • Open Access
7 Citations
5,254 Views
22 Pages

MG132 Induces Progerin Clearance and Improves Disease Phenotypes in HGPS-like Patients’ Cells

  • Karim Harhouri,
  • Pierre Cau,
  • Frank Casey,
  • Koffi Mawuse Guedenon,
  • Yassamine Doubaj,
  • Lionel Van Maldergem,
  • Gerardo Mejia-Baltodano,
  • Catherine Bartoli,
  • Annachiara De Sandre-Giovannoli and
  • Nicolas Lévy

10 February 2022

Progeroid syndromes (PS), including Hutchinson-Gilford Progeria Syndrome (HGPS), are premature and accelerated aging diseases, characterized by clinical features mimicking physiological aging. Most classical HGPS patients carry a de novo point mutati...

  • Editorial
  • Open Access
23 Citations
6,758 Views
8 Pages

25 February 2020

The nucleolus is a prominent, membraneless compartment found within the nucleus of eukaryotic cells. It forms around ribosomal RNA (rRNA) genes, where it coordinates the transcription, processing, and packaging of rRNA to produce ribosomal subunits....

  • Article
  • Open Access
4 Citations
3,246 Views
21 Pages

Hutchinson–Gilford progeria syndrome (HGPS) is a rare premature aging disease. It is caused by a mutation in the LMNA gene, which results in a 50-amino-acid truncation of prelamin A. The resultant truncated prelamin A (progerin) lacks the cleav...

  • Feature Paper
  • Article
  • Open Access
1 Citations
757 Views
15 Pages

12 November 2025

Cellular mechanical properties are critical indicators of cellular state and promising disease biomarkers. This study introduces a novel microhand system, featuring chopstick-like plate-shaped end-effectors, designed for stable and high-precision sin...

  • Article
  • Open Access
9 Citations
6,347 Views
40 Pages

Progeria and Aging—Omics Based Comparative Analysis

  • Aylin Caliskan,
  • Samantha A. W. Crouch,
  • Sara Giddins,
  • Thomas Dandekar and
  • Seema Dangwal

29 September 2022

Since ancient times aging has also been regarded as a disease, and humankind has always strived to extend the natural lifespan. Analyzing the genes involved in aging and disease allows for finding important indicators and biological markers for patho...

  • Review
  • Open Access
12 Citations
6,273 Views
11 Pages

7 November 2017

Premature aging disorders including Hutchinson-Gilford progeria syndrome (HGPS) and Werner syndrome, are a group of rare monogenic diseases leading to reduced lifespan of the patients. Importantly, these disorders mimic several features of physiologi...

  • Article
  • Open Access
3 Citations
2,897 Views
15 Pages

Use of Farnesyl Transferase Inhibitors in an Ageing Model in Drosophila

  • Annely Brandt,
  • Roman Petrovsky,
  • Maria Kriebel and
  • Jörg Großhans

29 October 2023

The presence of farnesylated proteins at the inner nuclear membrane (INM), such as the Lamins or Kugelkern in Drosophila, leads to specific changes in the nuclear morphology and accelerated ageing on the organismal level reminiscent of the Hutchinson...

  • Article
  • Open Access
14 Citations
3,209 Views
18 Pages

18 December 2020

Pseudoxanthoma elasticum (PXE) is a rare autosomal-recessive disorder that is mainly caused by mutations in the ATP-binding cassette sub-family C member 6 (ABCC6) gene. Clinically PXE is characterized by a loss of skin elasticity, arteriosclerosis or...

  • Article
  • Open Access
7 Citations
2,521 Views
17 Pages

The Activation of JAK/STAT3 Signaling and the Complement System Modulate Inflammation in the Primary Human Dermal Fibroblasts of PXE Patients

  • Christopher Lindenkamp,
  • Ricarda Plümers,
  • Michel R. Osterhage,
  • Olivier M. Vanakker,
  • Judith Van Wynsberghe,
  • Cornelius Knabbe and
  • Doris Hendig

29 September 2023

Previous studies revealed a link between inflammation and overactivation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling in syndromes associated with aging. Pseudoxanthoma elasticum (PXE), a rare autosomal-...

  • Article
  • Open Access
5 Citations
2,980 Views
29 Pages

16 October 2024

The human skin, the body’s largest organ, undergoes continuous renewal but is significantly impacted by aging, which impairs its function and leads to visible changes. This study aimed to identify botanical compounds that mimic the anti-aging e...

  • Case Report
  • Open Access
1 Citations
1,998 Views
12 Pages

Mesenchymal Stem Cell Therapy for Hutchinson–Gilford Progeria: Improvements in Arterial Stiffness and Bone Mineral Density in a Single Case

  • Eun-Young Joo,
  • Ji-Sun Park,
  • Hyun-Tae Shin,
  • Myungji Yoo,
  • Su-Jin Kim,
  • Ji-Eun Lee and
  • Gwang-Seong Choi

18 April 2025

Background/Objectives: Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic disorder that cause premature aging due to LMNA mutations and progerin accumulation. Although lonafarnib, an FDA-approved farnesyltransferase inhibitor, offers...

of 2